Director of API retires

By Dylan Bushell-Embling
Thursday, 10 July, 2008

A director of Australian Pharmaceutical Industries [ASX: API], Barry Frost, announced his retirement today.

Frost has served on the company's board since 1993, and has been deputy chairman since 2001. His resignation will be effective July 31.

API, which markets and distributes prescription and over-the-counter medications, has announced that it is currently looking for replacement for the position.

$96m RNA Research and Manufacturing Facility opens in NSW

The new 4500 sqm RNA Research and Manufacturing Facility within the Macquarie University...

Cartherics and Catalent announce enhanced partnership

To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...

Alliance seeks to boost regional capacity in clinical trials

Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is...

Content from other channels on our network

Clinical environments are changing. Healthcare solutions must change with them.

Doctors union accuses NSW Health of denying junior doctors study leave

Health Minister's Award for Nursing Trailblazers — nominations open

Pulse technology promises an atrial fibrillation treatment upgrade

One in five aged care residents receive delayed or missed denosumab doses

50 Years Strong: Celebrating Linco Food Systems in Australia (1975–2025)

Innovations in inspection solutions for meat, poultry and seafood

Feeding the future of snacking from end to end: five trends reshaping the sector

Technology report: Sensor solutions for dairy packaging

Why 2026 growth won't come from price rises: inventory systems back in focus

Renewables supply reaches almost 50% on Aust's east coast

Quantum timing study to help future-proof energy grid

New method to extract microplastics from soil: study

Water treatment plant receives 'Blue Loan'

Australians need to take care when recycling